Cochrane Response: Initial developments to meet rapid evidence needs

Topic category Knowledge translation and communicating evidence
Date and Location
Tuesday 2 October 2012 - 13:30 - 15:00
Contact persons and facilitators
Contact person Affiliation Country
Catherine Gallagher (Contact this person) George Mason University USA
Lorne Becker (Contact this person) SUNY Upstate Medical University USA
Juliane Ried (Contact this person) Cochrane Innovations Germany
Facilitator Affiliation Country
Lorne Becker SUNY Upstate Medical University USA
Catherine Gallagher George Mason University USA
Juliane Ried Cochrane Innovations Germany
Other contributors
First nameLast nameAffiliation and Country
First name: 
Last name: 
Affiliation and Country: 
Ottawa Hospital Research Institute, Canada
First name: 
Last name: 
Affiliation and Country: 
Ottawa Hospital Research Institute, Canada
Target audience
Target audience: 
Cochrane contributors or evidence users who require rapid turnaround of evidence for decision making
Is your workshop restricted to a specific audience or open to all Colloquium participants?: 
Level of knowledge required: 
Type of workshop
Type of workshop: 
Abstract text
To provide an open forum to present and discuss developments occurring as part of the new 'Cochrane Response' initiative led by Cochrane Innovations.

Decision making at the national and local level requires speed and contextualisation. Cochrane Review methods are by design exhaustive, with the highest potential to be generalisable and replicable, but sometimes the Cochrane model of investigator-initiated systematic reviews do not respond to decision makers' needs in terms of time and specificity.

The gap between Cochrane Reviews and national and local decision makers’ needs represents a potential quagmire of time and specificity: on the one hand, there is a tremendous market for quickly completed reviews that are designed to be sensitive to the local context; on the other hand, the Cochrane standard cannot be compromised by limiting the universe of evidence because of available time or geopolitical concerns. This leaves a broad middle ground, the vacuum of which is filled by makeshift strategies and commercial enterprises whose results are non-replicable.

Cochrane Response, an initiative of the Collaboration, is exploring potential means for meeting these needs, and will present progress to date. This session seeks the input and critique from all Cochrane users and contributors.